Literature DB >> 27540968

Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.

Michael Malek-Ahmadi1, Sylvia E Perez2, Kewei Chen1, Elliott J Mufson2,3.   

Abstract

The presence of Alzheimer's disease (AD)-related neuropathology among cognitively normal individuals has been well documented. It has been proposed that these individuals may represent a pre-clinical AD population. Previous studies have demonstrated a negative association between the presence of both amyloid-β (Aβ) plaques and neurofibrillary tangles with ante-mortem cognitive performance, a relationship which is likely influenced by a number of factors including age and APOE ɛ4 carrier status. The present study determined whether the presence of neuritic plaques (NPs) and diffuse plaques (DPs) are associated with performance in a number of cognitive domains after accounting for APOE ɛ4 carrier status and neurofibrillary tangle presence in a cohort of 123 older participants from the Rush Religious Order Study who died with a premortem clinical diagnosis of no cognitive impairment (NCI). After adjusting for age at death, education, gender, Braak stage, and APOE ɛ4 carrier status, the presence of NPs was associated with lower performance in the cognitive domains of Global Cognition (p = 0.002), Episodic Memory (p = 0.03), Semantic Memory (p = 0.009), and Visuospatial performance (p = 0.006), while DPs showed no association with any cognitive domain examined. These results suggest that decreases in cognition in elderly NCI individuals are associated with an increase in NPs and not DPs when age at death, education, gender, APOE ɛ4 status, and Braak stage are taken into consideration.

Entities:  

Keywords:  Amyloid-β; Braak stage; cognition; neuropathology; pre-clinical Alzheimer’s disease

Mesh:

Substances:

Year:  2016        PMID: 27540968      PMCID: PMC6314669          DOI: 10.3233/JAD-160365

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

1.  The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.

Authors:  Alexandra M Wennberg; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Mary M Machulda; Leonard Petrucelli; Michelle M Mielke; Clifford R Jack; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2019-01-21       Impact factor: 4.673

2.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

3.  Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.

Authors:  Lei Yu; Vladislav A Petyuk; Shinya Tasaki; Patricia A Boyle; Chris Gaiteri; Julie A Schneider; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

4.  Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia.

Authors:  Rosa S Valtanen; Catalin S Buhimschi; Mert O Bahtiyar; Guomao Zhao; Hongwu Jing; William E Ackerman; Charles G Glabe; Irina A Buhimschi
Journal:  Pregnancy Hypertens       Date:  2022-02-03       Impact factor: 2.494

5.  Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β.

Authors:  Kyeonghwan Kim; Jeong Hwa Lee; Sunmi Kim; Songmin Lee; Donghee Lee; Hye Yun Kim; Ikyon Kim; YoungSoo Kim
Journal:  RSC Med Chem       Date:  2021-10-11

Review 6.  Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Authors:  Elliott J Mufson; Milos D Ikonomovic; Scott E Counts; Sylvia E Perez; Michael Malek-Ahmadi; Stephen W Scheff; Stephen D Ginsberg
Journal:  Behav Brain Res       Date:  2016-05-13       Impact factor: 3.332

7.  Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Shaoli Che; Irina Elarova; Yinghua Chen; Freddy Jeanneteau; Thorsten M Kranz; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Hippocampus       Date:  2017-09-27       Impact factor: 3.899

8.  Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.

Authors:  Melissa K Edler; Chet C Sherwood; Richard S Meindl; William D Hopkins; John J Ely; Joseph M Erwin; Elliott J Mufson; Patrick R Hof; Mary Ann Raghanti
Journal:  Neurobiol Aging       Date:  2017-08-01       Impact factor: 4.673

9.  Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory.

Authors:  Julia Neitzel; Nicolai Franzmeier; Anna Rubinski; Michael Ewers
Journal:  Neurology       Date:  2019-06-24       Impact factor: 9.910

10.  Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility.

Authors:  Alifiya Kapasi; Lei Yu; Christopher Stewart; Julie A Schneider; David A Bennett; Patricia A Boyle
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.